An essential tool for detection of respiratory illnesses

By performing just a single test healthcare personnel is now able to simultaneously detect eighteen of the most prevalent respiratory infections in patients. The Seeplex 18-plex Respiratory Test is a highly economical method for molecular diagnostics of respiratory infections. It achieves results rapidly at minimal costs per test.

Photo: An essential tool for detection of respiratory illnesses

Seegene invents its new Seeplex 18-plex Respiratory Test as an essential tool for active surveillance and treatment of respiratory illnesses. Compared to the usual ‘single pathogen – single test’ testing regime the new multiplex-formatted diagnostic test, for which nasopharyngeal spirates, nasopharyngeal swabs or bronchoalveolar lavage samples could be used, is cost-effective and delivers fast results.

The Test detects the following  RNA viruses, DNA viruses and pneumonia bacteria:

      -          Influenza A virus
-          Influenza B virus
-          Human respiratory syncytial virus A
-          Human respiratory syncytial cirus B
-          Human parainfluenzae virus 1
-          Human parainfluenzae virus 2
-          Human parainfluenzae virus 3
-          Human coronavirus 229E/NL63
-          Human coronavirus OC43/HKU1
-          Human rhinovirus
-          Human enterovirus
-          Human adenovirus
-          Human bocavirus
-          Legionella pneumoniae
-          Streptococcus pneumoniae
-          Chlamydophila pneumoniae
-          Haemophilus influenzae
-          Mycoplasma pneumoniae

14.09.2007

More on the subject:

Related articles

Photo

Article • San Antonio Breast Cancer Symposium (SABCS)

Young women and breast cancer: research in focus

At the San Antonio Breast Cancer Symposium (SABCS), three experts presented new approaches and study results for the treatment of breast cancer in young women.

Photo

News • Combining spatial transcriptomics, pseudotime and machine learning

More precise than PSA: New biomarkers for prostate cancer found in urine

Using AI and extensive analyses of gene activity in tumours, researchers have found new, precise biomarkers to diagnose prostate cancer at an early stage through a simple urine sample.

Photo

News • Targeting early versions

A 'head start' in the race against pancreatic cancer

Fighting pancreatic cancer can feel like a race against time. A new discovery could give clinicians a head start - by targeting precancerous lesions before they become much more aggressive.

Related products

Subscribe to Newsletter